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Key Points
• Mechanistic modeling of
stable isotope labeling verifies
human neutrophil half-lives of
13-19 h in contrast to recent
estimates of .3 days.
• Human neutrophil kinetics
can be measured using a
single-dose deuterium-
labeled glucose protocol.
Human neutrophils have traditionally been thought to have a short half-life in blood;
estimates vary from 4 to 18 hours. This dogmawas recently challenged by stable isotope
labeling studies with heavy water, which yielded estimates in excess of 3 days. To
investigate this disparity, we generated new stable isotope labeling data in healthy adult
subjects using both heavy water (n 5 4) and deuterium-labeled glucose (n 5 9), a
compound with more rapid labeling kinetics. To interpret results, we developed a novel
mechanistic model and applied it to previously published (n 5 5) and newly generated
data. We initially constrained the ratio of the blood neutrophil pool to the marrow
precursor pool (ratio 5 0.26; from published values). Analysis of heavy water data sets
yielded turnover rates consistent with a short blood half-life, but parameters, particularly
marrow transit time, were poorly defined. Analysis of glucose-labeling data yieldedmore
precise estimates of half-life (0.796 0.25 days; 19 hours) andmarrow transit time (5.806
0.42 days). Substitution of this marrow transit time in the heavy water analysis gave a better-
defined blood half-life of 0.77 6 0.14 days (18.5 hours), close to glucose-derived values. Allowing the ratio of blood neutrophils to mitotic
neutrophilprecursors (R) tovaryyieldedabest-fitvalueof0.19.Reanalysisof thepreviouslypublishedmodelanddataalsorevealedtheorigin
of their longestimates forneutrophilhalf-life: an implicit assumption thatR isvery large,which isphysiologicallyuntenable.Weconclude that
stable isotope labeling in healthy humans is consistent with a blood neutrophil half-life of less than 1 day. (Blood. 2016;127(26):3431-3438)
Introduction
Maintenance of adequate numbers of circulating neutrophils is critical
for survival, but our understanding of how this is achieved is in-
complete. Some aspects of neutrophil development, such as the origins,
development, and maturation of bone marrow precursors,1-3 are well
characterized,whereas others, such as the dynamics of cell proliferation
and blood turnover, are more controversial.4 It is known that there is a
clear separation between the precursor expansion phase, which ter-
minates when cells become metamyelocytes,1 and the maturation
phase,which normally lasts about 5 to 6 days before release of cells into
the circulation,5 but the fate of cells after being released into the
circulation is more controversial.
Traditional dogma maintains that cells circulate for less than a day
before leaving the circulation; this may be even faster during infection
or trauma. Estimated half-lives in healthy individuals vary between 4.3
and17.5hours.4-6However, this dogmadatesback to early experiments
with cell transfer models and/or toxic or radioactive tracers.5,7-9
Interpretation of such experiments may have been confounded by cell
death (particularly because neutrophils are very susceptible to apoptosis
with any ex vivo manipulation) or direct effects from high-energy
radioactive tracers.4
A recent study by Pillay et al using in vivo stable isotope labeling
with heavy (deuterium-labeled) water (2H2O), which is nontoxic and
does not require cell manipulation, concluded that the previous es-
timates were incorrect; their estimate for the in vivo half-life of
circulating neutrophils was about 3.7 days (corresponding to a life span
of 5.4 days), an order of magnitude higher than previous estimates.10 If
true, this would represent a major paradigm shift in our understanding
of neutrophil kinetics. One potential explanation for this discrepancy
between historic and recent studies might be excess cell toxicity in
historic data leading to an overestimate of cell disappearance in these
earlier studies. A second potential explanation is the mathematical
model used to interpret the recent stable-isotope labeling curves.11 The
1-compartment model of Pillay et al may have failed to adequately
describe the behavior of a complex population that proliferates in a
remote (unmeasured) compartment (ie, bone marrow) and that is lost
from the sampled compartment (ie, blood). Furthermore, rapid cell
ﬂuxes may be difﬁcult to capture with heavy water, which labels and
delabels slowly (turnover rate,;5%/d).
One way to resolve this uncertainty would be to sample bone
marrow after deuterium labeling12; although undoubtedly revealing,
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this would require repeated marrow aspirations. We propose here an
alternative, less-invasive approach, combining a novel mathematical
model of granulopoiesis with the acquisition of new complementary
data using the short-lived label, deuterium-labeled glucose. To investi-
gate why Pillay et al10 obtained such large estimates, we acquired new
data using their label of choice (heavy water) and performed a re-
analysis of their published data.
The aims of this studywere to (1) testwhether a short-pulse labeling
protocol with deuterium-labeled glucose could be developed for
analysis of in vivo human neutrophil kinetics, (2) develop a physio-
logical yet parsimoniousmodel of neutrophil proliferation and loss, and
(3) reevaluate quantitative parameters of neutrophil kinetics (pro-
liferation rate, marrow transit time, and blood half-life) using data from
both published water-labeling data and new glucose- and heavy water-
labeling studies.
Methods
In vivo glucose labeling
Nine healthy adult subjects (aged 20-52 years; 6 men, 3 women; Table 1)
received deuterium-labeled glucose ([6,6-2H2]-glucose; Cambridge Isotopes,
Cambridge MA) as an oral solution. In initial studies, 60 g was given over 10
hours as half-hourly aliquots, preceded by a priming dose to rapidly achieve
steady-state labeling. Subsequent studies were modiﬁed to develop the simplest
workable protocol; dosing was progressively reduced (Table 1) to a single oral
dose of 20 g. Blood glucose enrichment was monitored during and after oral
labeling, as previously described.13 At selected time points after labeling,
neutrophils were isolated from blood by gradient centrifugation with Poly-
morphprep (Alere Technologies AS, Oslo, Norway); purity and yield were con-
ﬁrmed by ﬂow cytometry. In 2 subjects, C59 and C60, aliquots were further
puriﬁed by CD16 antibody-coated magnetic bead adhesion (Miltenyi Biotec,
Bisley, United Kingdom) and analyzed in parallel with cells puriﬁed by gradient
separation alone. DNAwas extracted, and deuterium enrichment was measured
by gas chromatography–mass spectrometry as previously described.13,14
In vivo heavy water labeling
Four further healthy subjects (aged 29-83 years; 3 men, 1 woman) received
heavy water for 7 weeks: 50 mL 70% 2H2O (Cambridge Isotopes) 3 times
daily for 1 week, then twice daily for 6 weeks, as previously described.14
During labeling and delabeling periods, saliva samples were collected to
measure the deuterium content in body water. Neutrophils were prepared
from the buffy coat layer below a Ficoll density gradient, and DNA was
processed and analyzed as above.
All subjects gave written informed consent after Ethical Review Board
approval (Ref 10/H0803/102 and13/LO/0022); all interventionswere performed
according to the principles of the Declaration of Helsinki.
Analysis of previously published in vivo heavy water
labeling data
Previously published15 in vivo heavy water labeling data from 5 subjects were
reanalyzed using the new model (see “Modeling”). Experimental details have
been published elsewhere.15 Brieﬂy, healthy young humans (aged 20-25 years)
received heavywater for 9weeks: a prime of 10mL 2H2O/kg bodyweight (BW)
over 24 h, followed by 1.25 mL 2H2O/kg BW daily. Cell samples were taken at
14 time points between week 0 and 16; urine samples were measured for body
water enrichment. DNA enrichments in neutrophils were measured by gas
chromatography–mass spectrometry.
Modeling
To interpret the experimental data, we constructed a new model based on the
known physiology of the granulopoietic system (Figure 1).16-22 Implicit are two
premises: (1) that mature circulating neutrophils acquire label as a consequence
of cell division during the mitotic stage in the bone marrow (ie, as myelocytes,
promyelocytes, myeloblasts, and so forth) and (2) that after the last mitosis,
metamyelocytes go through a maturation/transit process before release into the
circulation, resulting in a delayed appearance of labeled cells in blood. Model
equations are as follows:
dNpðtÞ
dt
¼ p×NpðtÞ2 q×NpðtÞ[1]
dNbðtÞ
dt
¼ s×Npðt2DÞ2 z×NbðtÞ[2]
where Np is the number of proliferating bone marrow neutrophils and Nb is the
number of blood neutrophils at time t. Np proliferate at a rate p and leave the
proliferating pool at rate q into the postmitoticmaturation/transit poolwhere they
reside for timeD. After the transit timeD, neutrophils enter into the circulation at
rate s and exit the circulation at rate z.
In the presence of label, deuterium is incorporated into neutrophil DNA
during division of theNp pool in the bonemarrow. Assuming that the amount of
DNA per cell is conserved (amount of DNA proportional to the number of
neutrophils), the model equations can be written as follows:
dNLpðtÞ
dt
¼ p×NpðtÞ×UðtÞ×bw=g2 q×NLpðtÞ[3]
dNLbðtÞ
dt
¼ s×NLpðt2DÞ2 z×NLbðtÞ[4]
whereNL are labeled neutrophils, bw/g is the normalizing factor of eitherwater or
glucose, respectively,13,14,16,23 andU(t) represents label enrichment (instantaneous
Table 1. Participants and dosing for human deuterium-labeled glucose and heavy water studies
Subject identifier Age, y Sex Label Total dose* Labeling time
C36R 52 Male Deuterium-labeled glucose 60 g 10 h
C41 28 Female Deuterium-labeled glucose 60 g 10 h
C42 44 Female Deuterium-labeled glucose 30 g 4 h
C46 28 Female Deuterium-labeled glucose 20 g 3 h
C48 36 Male Deuterium-labeled glucose 20 g 3 h
C49 30 Male Deuterium-labeled glucose 20 g 3 h
C50 27 Male Deuterium-labeled glucose 20 g 3 h
C59 20 Male Deuterium-labeled glucose 20 g Bolus
C60 21 Male Deuterium-labeled glucose 20 g Bolus
DW04 83 Male Heavy water 5250 mL 7 wk
DW09 47 Male Heavy water 5250 mL 7 wk
DW10 34 Male Heavy water 5250 mL 7 wk
DW11 29 Female Heavy water 5250 mL 7 wk
*Total volume of heavy water is shown as milliliters of 70% 2H2O; dosing was 50 mL 3 times daily for 1 week and then twice daily for 6 weeks.
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exposure to label) at time t approximated by the experimental plasma label
enrichment. U(t) was described by an empirical curve for water labeling
studies15; by a square-pulse approach with exponential tail for the 3-hour,
4-hour, and 10-hour labeling protocols; and by interpolation between data
points for the single oral bolus approach (C59 and C60) (supplemental Text
1, available on the Blood Web site).
Assuming a constant number of cells in each pool, the steady-state constraint
requires that thenetﬂowof the systemequals0 (p·Np(t)5q·Np(t)5 s·Np(t2D)5
z·Nb(t), from Equations 1 and 2). Using these constraints to eliminate p, q,
and s and dividing Equations 3 and 4 by the number of cells in each
pool gives Equations 5 and 6, where L is the fraction of labeled
neutrophils in the proliferating pool (Lp) and in blood (Lb), and R is the
ratio of blood neutrophils to mitotic neutrophil precursors in marrow
(R 5 Nb/Np).
dLpðtÞ
dt
¼ z×R×UðtÞ×bw=g2 z×R×LpðtÞ[5]
dLbðtÞ
dt
¼ z×Lpðt2DÞ2 z×LbðtÞ[6]
Thismodel, therefore, has up to 3 free parameters (z, R, andD; see “Estimation of
the ratio of blood neutrophils to bone marrow mitotic precursors (R)”).
Estimation of the ratio of blood neutrophils to bone marrow mitotic
precursors (R). We deﬁned R as the ratio of the number of neutrophils in
blood to the number of mitotic neutrophils in marrow. Initially, we ﬁxed R
using estimates derived from the literature (R 5 0.26; Box 1). This value
was used when ﬁtting each individual separately. In later analysis, we
allowed R to be a free parameter, which we estimated from ﬁtting the model
to all individuals simultaneously (R, z, and D were population parameters).
Fitting procedure and expression of results. Equations 5 and 6 were
ﬁtted to the experimental data by minimizing the sum of squared residuals
between prediction and observation using the pseudorandom algorithm
in the R-package Flexible Model Environment (FME).24-26 Standard
errors on estimates were calculated using the asymptotic covariance
matrix method.27
When comparing our conclusions with other estimates in the literature, the
reader shouldbe aware thatwehavequotedhalf-life values (t1/25 ln(2)/z),which
are a factor of 1.44 less than life span values (1/z).
Results
Experimental exploration of neutrophil kinetics using
deuterium-labeled glucose
Neutrophil labeling after dosing with deuterium-labeled glucose
showed a consistent pattern (Figure 2) characterized by a lag period
of 5 to 7 days with no appreciable labeling, a rapid increase in the
proportion of labeled cells, and then a slower disappearance. Because
deuterium enrichments in the DNA of circulating neutrophils in initial
experiments with a 60 g/10 h dosing schedule were high in the
measurement range, we sought to develop the simplest, least-intrusive,
and most cost-effective protocol by progressively reducing the dose
and duration of labeling. Our ﬁnal protocol, 20 g given as a single dose
(Table 1), yielded enrichments in the readily measurable range,
typically 0.5 atom percent enrichment; further dosage reductions may
be feasible while still obtaining reliable results. Subject acceptability
was good, although repeated postlabeling measurements (we estimate
at least 6 time points) were required to capture the lag, peak, and
disappearance phases adequately.
Modeling of heavy water–derived and deuterium-labeled
glucose–derived data sets
We developed a 2-compartment model in which neutrophils acquire
label as a consequence of cell division during the mitotic stage in the
bone marrow (ie, as myelocytes, promyelocytes, myeloblasts, and so
forth) and then go through amaturation/transit phase (metamyelocytes)
before release into the circulation (Figure 1). The ratio of the size of the
total blood neutrophil pool to the bone marrow neutrophil precursor
mitotic pool (ie, R)was initially ﬁxed at a value derived from published
literature (0.26; Box 1); later, we explored the implications of allowing
R to be a free parameter. We ﬁtted this model to the experimental data
to estimate the rate of neutrophil disappearance from the blood (z) and
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Figure 1. Physiology of granulocyte turnover translated to a model.We consider mitotic neutrophil precursors as a single pool, Np (proliferating neutrophils). The Np pool
consists mainly of myelocytes, promyelocytes, and myeloblasts but also contains earlier precursors. Cells in the Np population proliferate at a mean rate p. After the last
mitosis, cells enter the postmitotic maturation/transit pool at a rate q. Transit neutrophils remain in the postmitotic pool for a period of 4 to 6 days,5,16,17 referred to as the transit
time (D), before egressing from bone marrow into the blood pool. Most egressing cells are segmented neutrophils, but some cells leave as band neutrophils. In the blood,
neutrophils exist both in a freely circulating pool and a marginal pool (cells retained in proximity to the endothelium). Because the circulating and marginal pool are considered
to be in rapid dynamic equilibrium,7,8 we consider them a single kinetically homogeneous pool, NB. Blood neutrophils are lost from the circulation at a rate z primarily to the
bone marrow, liver, and spleen.18-20 This loss is generally considered to be a random, irreversible process.5,8,17,21,22 GMP, granulocyte-monocyte progenitor cells; HSC,
hematopoietic stem cell.
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the bone marrow transit time (D). The model ﬁtted the new water
and glucose data and the published heavy water data well, with the
exception of 1 individual (C42) whose data were not consistent
with other data sets (Figures 2 and 3). Parameters estimates are
given in Table 2. Glucose-labeling experiments yielded values
for the median marrow transit time of 5.72 days (mean 6 SD,
5.806 0.42 days), with a mean6 SD neutrophil half-life in blood
of 0.79 6 0.25 days (19 6 6 hours, equivalent to a life span of
1.05 days). Heavy water studies gave not dissimilar values for the
half-life in blood of 1.11 6 0.36, days but parameter estimates were
poorly resolved, especially the postmitotic transit time, which had
a wide interindividual range and large standard errors (range,
0.41-5.91 days;mean6SD, 3.46 2.09 days; supplemental Figure 1,
subjects A-E and DW04-DW11); similarly a wide range of values
of z ﬁtted the data equally well (supplemental Figure 2, subjects A-E
and DW04-DW11). In contrast, estimates from glucose labeling
were better resolved (Table 2, C36R-C60; supplemental Figures 1
and 2, C36R-C50).
We hypothesized that the slightly longer half-life estimates for the
water data set could be an artifact of the poor estimates of the transit
Box 1: Estimation of R from the published literature
We deﬁne R as the ratio of the number of neutrophils in blood to the number of mitotic neutrophil precursors in bone marrow. We
assume R is constant for all individuals. We estimate R by estimating each pool size from values in the published literature.
Total blood neutrophil pool size
The mean count of circulating blood neutrophils for the white population has been estimated to be 4.2 3 109 cells per liter.28 The
blood volume of the 73-kg reference man is 5.3 L.29 This gives an estimate for the circulating pool of 3.05 3 108 cells per kilogram
BW. In addition to the circulating pool, the total blood pool also includes the marginal pool; because this is in fast equilibrium with
the circulating pool, we consider them to be a single kinetically homogeneous population.8 The size of the marginal pool has been
estimated by different methods. Labeling studies suggest a value of between 43% and 58% of the total blood granulocyte pool,5,7,8
but these studies were performed under conditions that might affect neutrophil kinetics. Studies using epinephrine (which mobilizes
the marginal blood pool without affecting the total blood pool size7,30), suggest that the marginal pool size accounts for 50% to 55%
of the total neutrophil blood pool.31,32 Taking the more conservative value (50%) gives an estimate of the total blood granulocyte
pool (marginal and circulating) of 6.1 3 108 cells per kilogram BW, the value used in this study. Notably, it agrees closely with the
estimate of 7 3 108 cells per kilogram BW published by Cartwright et al.8
Bone marrow mitotic neutrophil pool size
Mitotic neutrophils include myeloblasts, promyelocytes, and myelocytes, with a minor contribution from the stem cell pool.33 Flow
cytometry and microscopy studies suggest that mitotic neutrophils in marrow account for 17% to 19% of total marrow
cellularity.2,34,35 The cellularity of bone marrow has been extensively studied in mice36-38 and humans39-43; the median of these
different estimates is 13.05 3 109 cells per kilogram (supplemental Table 1). Taking a value of 17% for the marrow neutrophil
precursor mitotic pool gives an estimate of 2.35 3 109 cells per kilogram (the value used in this study), in line with the estimate
provided by Dancey et al of 2.11 3 109 cells per kilogram.5
Estimation of the ratio of blood neutrophils to bone marrow mitotic precursors (R) from published values
Combining these values, a total blood neutrophil pool of 6.1 3 108 cells per kilogram and a marrow neutrophil precursor mitotic
pool of 2.35 3 109 cells per kilogram yields an estimation of R of 0.26.
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Figure 2. Best model fits to neutrophil DNA enrichment data in subjects labeled with deuterium-labeled glucose. Subjects were labeled with deuterium-labeled
glucose (6,6-2H2-glucose) for 10 hours (C36R and C41), 4 hours (C42), 3 hours (C46, C48, C49, and C50), or as a single oral dose (C59 and C60). Circles represent
measured fractional enrichment of deoxyadenosine in blood neutrophil DNA; lines represent best fits of the model (Equations 5 and 6) to the data.
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times. Hence, we repeated the ﬁts to the water data sets with a ﬁxed
transit timeof 5.7 days, a value consistent bothwith historical data5,16,44
and our estimates from glucose labeling. The resulting estimates for
the half-life of neutrophils (mean 6 SD, 0.77 6 0.14 days), were not
only better resolved but also remarkably consistent with the glucose-
based estimates (Table 3). The quality of the ﬁt (deviation between
observation and prediction) with free and ﬁxed transit times was very
similar. Therefore, if R is ﬁxed, based on estimates from the literature,
and if a glucose/literature-derived value for transit time is used for
heavy water modeling, then both approaches give almost identical
estimates of the key kinetics of neutrophil homeostasis and provide
good ﬁts to the experimental data.
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Figure 3. Best model fits to neutrophil DNA enrichment data in subjects labeled with heavy water. Subjects were labeled with heavy water (2H2O) for 9 weeks (subjects
A, B, C, D, E from Vrisekoop et al15) or 7 weeks (subjects DW04, DW09, DW10, and DW11 from the current study’s data). Circles represent measured fractional enrichment of
deoxyadenosine in blood neutrophil DNA; lines represent best fits of the model (Equations 5 and 6) to the data.
Table 2. Best fit parameters derived from deuterium labeling experiments
Subject identifier Normalization factor, bg/w* Transit time, D, d† Loss rate from blood, z, d
21‡ Proliferation rate, p, d21§ Blood half-life, d‖
Deuterium-labeled glucose
C36R 0.73{ 5.91 6 0.07 1.03 6 0.04 0.268 0.67
C41 0.73{ 5.56 6 0.00 1.06 6 0.19 0.276 0.65
C42 0.73{ 5.38 6 0.00 0.52 6 0.08 0.135 1.34
C46 0.73{ 5.72 6 0.00 1.09 6 0.05 0.283 0.63
C48 0.73{ 5.29 6 0.07 0.72 6 0.12 0.187 0.97
C49 0.73{ 5.88 6 0.00 0.92 6 0.06 0.239 0.76
C50 0.73{ 6.60 6 0.72 1.42 6 0.29 0.369 0.49
C59 0.73{ 5.61 6 0.00 0.82 6 0.00 0.213 0.85
C60 0.73{ 6.24 6 0.01 0.98 6 0.00 0.255 0.71
Mean 6 SD 5.80 6 0.42 0.95 6 0.29 0.247 6 0.066 0.79 6 0.25
Median 5.72 0.98 0.255 0.71
Heavy water
A 4.32 6 0.03 4.49 6 0.00 0.74 6 0.02 0.192 0.94
B 4.74 6 0.05 4.69 6 0.62 0.77 6 0.09 0.200 0.90
C 4.89 6 0.07 5.25 6 0.35 0.78 6 0.00 0.203 0.89
D 3.69 6 0.11 1.77 6 0.07 0.47 6 0.04 0.122 1.49
E 3.98 6 0.06 0.41 6 0.00 0.53 6 0.03 0.138 1.31
DW04 4.40 6 0.31 5.91 6 0.00 1.18 6 0.09 0.307 0.59
DW09 3.83 6 0.19 0.84 6 2.82 0.40 6 0.11 0.104 1.74
DW10 4.38 6 0.00 5.07 6 1.97 0.73 6 0.00 0.190 0.96
DW11 3.18 6 0.14 2.20 6 2.29 0.57 6 0.17 0.148 1.21
Mean 6 SD 4.16 6 0.54 3.40 6 2.09 0.68 6 0.23 0.178 6 0.060 1.11 6 0.36
Median 4.32 4.49 0.73 0.190 0.96
Parameter estimates are shown with their standard error estimated from the asymptotic covariance matrix; mean values are shown with their standard deviation (SD).
*Normalization factors are bg and bw for glucose and water, respectively.
†Transit time, D, is the time from the last mitosis in marrow until cell egression to blood.
‡Loss rate from blood, z, is the loss rate of blood neutrophils.
§The proliferation rate of mitotic neutrophils, p, is not a free parameter; it is calculated from the other model parameters: p 5 z×R.
‖Half-life is calculated from the loss rate z, as ln2/z.
{Denotes a fixed value.
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Validation of the ratio of blood neutrophils to bone marrow
mitotic precursors (R)
Our initial approach relied on estimating R from the published
literature. To investigate the accuracy of this estimate, we simulta-
neously ﬁtted the data from the previously published 9-week heavy
water labeling and our 3-hour and 10-hour oral glucose labeling data
sets;we let z, transit time, andRbe free populationparameters;C42was
excluded at this point because this subject’s data were not consistent
with other individuals and we were concerned that this may have a
distorting effect on the estimate of R. To minimize the number of free
parameters, bg and bw were ﬁxed, bg to 0.73
13 and bw to 1, by
normalizing the water data to 100%.15 The latter normalization could
not be carried out for the 7-week labeling data set due to the uncertainty
in having reached 100%of the attainable label in neutrophilDNA15; for
this reason, the 7-week data set was excluded from estimates of R. We
found 2 scenarios that ﬁtted the data equally well (supplemental
Figure 3), as previously hypothesized11; one with R 5 0.19 6 0.00
(transit time, 5.72 days; half-life, 13 hours), and another with R5 5.49
61.26 (transit time, 5.73 days; half-life, 3 days). In the former scenario,
marrow maturation/transit time is the rate-limiting step, whereas in the
latter, the cell disappearance from the blood is also slow, as previously
described.11 Focusing on theﬁrst scenario,which produces estimates of
R similar to those in the literature, we see that our estimates of
neutrophil half-life are reasonably robust to the assumed value of R,
being only slightly lower with a free value of R than with a ﬁxed value.
This analysis also showed that a second scenario was numerically
possible but physiologically unlikely because an R on the order of 5 is
incompatible withwhat is known about the relative sizes of themarrow
and blood compartments.
Comparison of our estimates of neutrophil half-life with those
obtained by Pillay et al
Our estimates of neutrophil half-life are consistent with a short half-life
of less than 1 day, whether we ﬁt to our newly obtained data or the data
presented by Pillay et al10 and whichever label we use. Thus, the
difference in estimated half-life must be attributable to model choice,
not data. Comparison of our model with that of Pillay et al
(supplemental Text 2) shows that Pillay et al implicitly assume that R
is large, an assumption that is at odds with current knowledge of the
system. Furthermore, it can be seen (supplemental Figure 3) that as R is
increased, the estimate of the circulating half-life increases, explaining
why Pillay et al obtained such large estimates for the half-life. We
suggest that because R is thought to be small (on the order of 0.2), our
shorter estimates of neutrophil half-life are more likely to be accurate.
Discussion
Neutrophil proliferation and maturation/transit in marrow, egression to
blood, and loss rates from blood have recently received unprecedented
attention. Revised estimates for neutrophil life span in blood, generated
from heavy water experiments (mean life span of 5.4 days, cor-
responding to a half-life of 3.7 days) conﬂict with the widely ac-
cepted dogma that neutrophils spend only a very short period in blood
(generally considered to be about 11 hours, corresponding to a half-life
of 7.6 hours5). Li et al11 observed that this disparity could result from
data interpretation using a single-compartment model. Applying a
multicompartment model to the tritium-labeled thymidine data of
Dancey et al,5 they showed that 2 distinct scenarios are mathematically
plausible: one where the time taken for proliferation and transit in
marrow is rate limiting, and another in which the circulatory half-life is
the rate-limiting step.11 We conﬁrmed the mathematical plausibility of
these 2 scenarios using a 2-compartment model with deuterium-
labeling experimental data, albeit with slightly longer half-lives in both
situations. Crucially, we observed that a pivotal difference between the
2 scenarios correlates with different relative sizes of the marrow
precursor and blood neutrophil pools. We hypothesized that focusing
on this aspectmight allow resolutionof thedilemmawithout recourse to
invasive bone-marrow sampling experiments. We also hypothesized
that parameter estimates should be independent of the kinetics of the
tracer used and so should yield similar conclusions whether derived
from heavywater or deuterium-labeled glucose when interpreted using
a 2-compartment model. Our studies have enabled us to draw several
conclusions.
First, in terms of experimental approaches,we found that deuterium-
labeled glucose labeling allowed estimation of the key parameters of
neutrophil kinetics with a simple, short, readily executed protocol.
Administration of a single oral dose achieves adequate enrichment for
quantitation, although repeated follow-up blood sampling is required.
Because neutrophils are highly labeled, minor cellular impurities have
a relatively small effect and cell sorting by dual-gradient density cen-
trifugation appears adequate; parallel studies with and without further
magnetic bead puriﬁcation in 2 subjects yielded almost identical
enrichment results (supplemental Figure 4). The single-dose deuterium-
labeled glucose approach with 2-compartment modeling appears to
represent a potentiallywidely applicablemethod for the study of human
neutrophil kinetics in vivo.
Second, in terms of modeling, we conﬁrmed that estimation of
parameters is critically related to the relationship between the size of the
marrow precursor and blood neutrophil pools. Fixing this ratio of pool
Table 3. Revised parameter estimates for water data sets after fixing the transit time
Identifier Normalization factor, bw Transit time, D, d* Loss rate from blood, z, d
21 Proliferation rate, p, d21 Blood half-life, d
Heavy water
A 4.30 6 0.03 5.7* 0.93 6 0.00 0.242 0.75
B 4.72 6 0.02 5.7* 0.96 6 0.01 0.250 0.72
C 4.88 6 0.07 5.7* 0.84 6 0.00 0.218 0.82
D 3.59 6 0.12 5.7* 0.84 6 0.00 0.218 0.82
E 3.89 6 0.04 5.7* 1.34 6 0.16 0.348 0.52
DW04 4.40 6 0.15 5.7* 1.13 6 0.24 0.294 0.62
DW09 3.65 6 0.20 5.7* 0.68 6 0.00 0.177 1.01
DW10 4.37 6 0.25 5.7* 0.80 6 0.19 0.208 0.87
DW11 3.14 6 0.14 5.7* 0.92 6 0.19 0.239 0.75
Mean 6 SD 4.10 6 0.57 0.94 6 0.19 0.244 6 0.051 0.77 6 0.14
Median 4.30 0.92 0.239 0.75
Parameters are as explained in Table 2.
*Values denote the fixed value of transit time, D, in this model.
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sizes at 0.26 (from published values for physiological variables; Box 1)
allowed us to obtain unique best ﬁts for key parameters in neutrophil
kinetics. Poor parameter estimates for heavy water could be attributed
to the difﬁculty in estimating themarrow transit timeusing a tracerwith
a slow “on” and “off” dynamic. When externally derived values for
transit time were ﬁxed for the heavy water data, much more precise
estimates for the keyparameterswere obtained,whichwere remarkably
close to those obtained from glucose-labeling experiments.
In addition, wewere able to demonstrate the source of the very high
estimates of circulatory half-life previously calculated by Pillay et al
(supplementalText 2). It seems that themajor problemof thepreviously
described 1-compartment model is the implicit assumption that the
number of proliferating neutrophil precursors in marrow is small
compared with the number of neutrophils in blood, leading to a very
high estimate of the neutrophil half-life. This assumption clashes with
current knowledge of neutrophil cell population sizes in bone marrow
and blood.
Third, in terms of the physiological implications of these ﬁndings,
we found that, for ﬁxed R, stable isotope labeling data were consistent
with the traditional dogma of a rapid turnover of blood neutrophils.
Mean values for the circulatory half-lives were 19 and 18 hours for
glucose and water, respectively. We further conﬁrmed that in healthy
individuals, the postmitotic transit time is about 5.7 days. When R is
allowed to be a free parameter, we estimate a slightly shorter neutrophil
half-life of 13 hours. These estimates are in good agreement with
previous half-life estimates obtained both by labeling5,7-9 and an inde-
pendent (label-free) method based on ﬁtting a model of myelosup-
pression to antitumor treatment data sets.45 When the model presented
here, with R5 0.26, isﬁtted to tritium-labeled thymidine data available
in the literature,1,5 a blood half-life of 13 to 16 hours is obtained, which
is slightly smaller than the estimates obtained from heavywater and
glucose using the same value of R. It is well known that ex vivo
manipulation of neutrophils or the use of toxic compounds such as
radioactive diisopropyl ﬂuorophosphate, 5-bromo-29-deoxyuridine,
and tritium-labeled thymidine may affect the viability of cells,
affect their kinetics and plasticity, and/or increase their sequestra-
tion in organs.46-50 As discussed elsewhere,4 this may explain these
remaining discrepancies.
Althoughmore complexmodels can readily be developed, they did
not change our basic conclusion that neutrophil half-life is short,
although precise estimates did vary (3-16 hours, depending on model).
None of the models provided a better ﬁt to the labeling data than our
current model choice (data not shown). Other scenarios considered
included concatenated series of mitotic pools in marrow, a discrimi-
nation between marginal/circulating blood pools, egression from
marrow deﬁned by different probability density functions, and age-
dependent loss in blood. The current model assumes a steady state;
application to non-steady-state situations such as trauma and sepsis
may be attained by the inclusion of a feedback loop affecting
proliferation, as has been done before in studies ofmyelosuppression
upon antitumor treatment.45,51,52 Similarly, circadian oscillations are
not included within the steady-state model. Blood neutrophil counts
follow a circadian rhythm,53,54 which may be due to changes in
proliferation, transit/release, or death/disappearance. Heavy water
labels throughout the 24-hour cycle while glucose labeling was
always performed in daylight hours (photophase); samples were
consistently taken in the earlymorning (8:00-10:00 AM). The fact that
photophase labeling with glucose and continual (photophase and
scotophase) labelingwith water gave similar estimates for neutrophil
proliferation and dwell time suggests that there are probably not very
large variations in these parameters with phase of the circadian
clock. A more detailed analysis of the potential impact of circadian
oscillations is, however, beyond the scope of this paper.
In summary, application of a mechanistic, biologically meaningful
model demonstrates that in vivo deuterium-labeling data, whether
obtained using heavy water or glucose, is consistent with a half-life for
neutrophils in bloodof less than aday.Wehave shownhow longer half-
livesmay bemathematically consistentwith the data, but onlywhen the
relative sizes of the blood and marrow pools are allowed to assume
nonphysiological values. This model has wider potential applications,
including investigation of cells such as some T-cell populations,
leukemic cells, and monocytes, in which proliferation and sampling
occur in different compartments.
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